This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
7
Check minimum number of events None
7
Include endpoints None
7
Remove individuals based on genotype QC
7
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Hypersecretion of calcitonin based on the number of shared cases.
Broader endpoints:
- Other disorders of thyroid
- Disorders of thyroid, IBD co-morbidities
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 7 | 7 | - |
Unadjusted prevalence (%) | 0.00 | 0.00 | - |
Mean age at first event (years) | 46.74 | 46.74 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_HYPERSECCAL – Hypersecretion of calcitonin
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hypersecretion of calcitonin
↥Endpoint not on priority list, no data to show.